Mansour bin Zayed attends inauguration of ADSCC Congress 2023

November 20, 2023 / 7:58 PM
Sharjah 24 – WAM: Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Chairman of the Presidential Court, witnessed the inauguration of ADSCC Bone Marrow Transplant Cellular Therapy Congress 2023 in Abu Dhabi, organised by Abu Dhabi Stem Cells Centre (ADSCC), a subsidiary of PureHealth.
In addition to meeting some of the congress international speakers and ADSCC physicians and scientists, Sheikh Mansour met with five ADSCC patients including the first to receive the UAE’s first locally manufactured CAR-T Cells, and patients who underwent bone marrow transplant procedures for luekemia, krabbe disease and multiple sclerosis at ADSCC.

Sheikh Mansour reviewed the latest developments and achievements of the Abu Dhabi Stem Cells Cener and its future projects in stem cell therapies and regenerative medicine, notably the regeneration of pancreatic cells and the use of brain stem cells to treat neurological diseases, focusing on multiple sclerosis. His Highness praised the Abu Dhabi Stem Cells Centre team's dedicated efforts, that reflects the unlimited support of UAE’s leadership.

He support is a testament to UAE’s commitment to advancing medical research and healthcare in Abu Dhabi on a global scale.

The ceremony was attended by Mansour Al Mansouri, Chairman of the Department of Health Abu Dhabi, Farhan Malik, CEO of PureHealth in addition to top government officials, senior leadership from PureHealth and ADSCC, and officials from the UAE and regional healthcare sector.

Hosted by ADSCC, the congress featured more than 60 leading expert physicians, researchers, and scientists from more than 15 countries including the United States, Japan, Italy, Canada, the United Kingdom, Switzerland, South Korea, and others, who came together under a shared goal to drive innovation and collaboration in bone marrow transplant, cellular therapy, and regenerative medicine with more than 64 different scientific lectures and talks. The congress was attended by more than 1500 healthcare professionals. The congress is considered the first-of-its-kind in the UAE and supports the vision of ADSCC towards revolutionising healthcare globally through innovation.

The congress, accredited for up to 36 Continuous Medical Education (CME) hours to attending healthcare professionals, featured two in-parallel educational tracks, providing an open platform for education and discovery, with a focus on uncovering ground-breaking treatments for diseases such as MS, cancer, GVHD (Graft-versus-host disease) and musculoskeletal disorders.

The ADSCC Bone Marrow Transplant and Cellular Therapy Congress 2023 was also proud to host the National MS Society UAE, a leading organisation advocating for and improving the lives of people with multiple sclerosis (MS), which was attended by more than 70 individuals. Following the success of the ADSCC Bone Marrow Transplant Cellular Therapy Congress 2023, ADSCC has announced the second edition of the event on 26th and 27th October 2024.

November 20, 2023 / 7:58 PM

More on this Topic

Rotate For an optimal experience, please
rotate your device to portrait mode.